Abstract:Abstract Background Alzheimer’s disease is the most common neurodegenerative disease in the elderly. Amyloid-β protein (Aβ) is the major component of neuritic plaques which are the hallmark of AD pathology. β-site APP cleaving enzyme 1 (BACE1) is the major β-secretase contributing to Aβ generation. β-site APP-cleaving enzyme 2 (BACE2), the homolog of BACE1, might play a complex role in the pathogenesis of Alzheimer’s disease as it is not only a θ-secretase but also a conditional β-secretase. Dysregulation of BACE2 is observed in Alzheimer’s disease. However, the regulation of BACE2 is less studied compared with BACE1, including its degradation pathways. In this study, we investigated the turnover rates and degradation pathways of BACE2 in both neuronal cells and non-neuronal cells. Results Both lysosomal inhibition and proteasomal inhibition cause a time- and dose-dependent increase of transiently overexpressed BACE2 in HEK293 cells. The half-life of transiently overexpressed BACE2 protein is approximately 6 h. Moreover, the half-life of endogenous BACE2 protein is approximately 4 h in both HEK293 cells and mouse primary cortical neurons. Furthermore, both lysosomal inhibition and proteasomal inhibition markedly increases endogenous BACE2 in HEK293 cells and mouse primary cortical neurons. Conclusions This study demonstrates that BACE2 is degraded by both the proteasome and lysosome pathways in both neuronal and non-neuronal cells at endogenous level and in transient overexpression system. It indicates that BACE2 dysregulation might be mediated by the proteasomal and lysosomal impairment in Alzheimer’s disease. This study advances our understanding of the regulation of BACE2 and provides a potential mechanism of its dysregulation in Alzheimer’s disease.

Receptor Tyrosine Kinases Positively Regulate BACE Activity and Amyloid-β Production Through Enhancing BACE Internalization

A GPCR/secretase Complex Regulates Β- and Γ-Secretase Specificity for Aβ Production and Contributes to AD Pathogenesis

Alzheimer's Β-Secretase (BACE1) Regulates the Camp/pka/creb Pathway Independently of Β-Amyloid.

Control of App Processing and A Beta Generation Level by Bace1 Enzymatic Activity and Transcription

Lys203 and Lys382 Are Essential for the Proteasomal Degradation of BACE1

Mitochondrial Respiratory Inhibition and Oxidative Stress Elevate Β-Secretase (BACE1) Proteins and Activity in Vivo in the Rat Retina

Increased Expression of Reticulon 3 in Neurons Leads to Reduced Axonal Transport of Β Site Amyloid Precursor Protein-cleaving Enzyme 1

RCAN1 Inhibits BACE2 Turnover by Attenuating Proteasome-Mediated BACE2 Degradation

Distinct Transcriptional Regulation and Function of the Human Bace2 and Bace1 Genes

Activation of Β2-Adrenergic Receptor Stimulates Γ-Secretase Activity and Accelerates Amyloid Plaque Formation

Interaction Between Amyloid Precursor Protein and Nogo Receptors Regulates Amyloid Deposition

New Protein Kinase C Activator Regulates Amyloid Precursor Protein Processing In Vitro By Increasing Alpha-Secretase Activity

The Effect of BACE1-AS on Β-Amyloid Generation by Regulating BACE1 Mrna Expression

Beta Secretase Localization, Amyloid Deposition And Aberrant Synaptic And Neuritic Sprouting In Transgenic Mouse Alzheimer Models: A Role For Bace1 In Synaptic Remodeling And Plaque Formation?

Regulation Of Alzheimer'S Disease Amyloid-Beta Formation By Casein Kinase I

BACE2 Degradation is Mediated by Both the Proteasome and Lysosome Pathways

Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling

Delta- and Beta-Secretases Crosstalk Amplifies the Amyloidogenic Pathway in Alzheimer's Disease

β-Secretase 1’s Targeting Reduces Hyperphosphorilated Tau, Implying Autophagy Actors in 3xTg-AD Mice

BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.

Delta- and beta- secretases crosstalk amplifies the amyloidogenic pathway in Alzheimer’s disease